超高效液相色谱-四极杆-飞行时间质谱法快速辨识芪玉三龙汤化学成分

利用超高效液相色谱-四极杆-飞行时间质谱(UPLC-QTOF-MS)的数据非依赖性采集(DIA)技术,结合靶向筛查方法,快速辨识芪玉三龙汤(Qi-Yu-San-Long decoction,QYSLD)化学成分.以Waters ACQUITY UPLC BEH C18柱(100 mm×2.1 mm,1.7μm)为色谱柱...     

经典名方当归四逆汤物质基准的关键质量属性研究

该文建立了当归四逆汤物质基准的高效液相色谱(HPLC)特征图谱及多指标含量测定方法,阐明了当归四逆汤物质基准的关键质量属性,完善了其质量控制体系.使用的色谱柱为PomenexLuna?C18(250 mm×4.6 mm,5 μm),流动相为乙腈-0.05％磷酸水溶液,体积流量为1.0 mL·min-1,梯度洗脱,进样量...     

葛根芩连汤联合西药治疗小儿毛细支气管炎的疗效研究

目的研究葛根芩连汤联合西药治疗小儿毛细支气管炎的疗效。方法将2012年3月—2014年5月期间住院治疗的120例毛细支气管炎患儿纳入研究,根据治疗方式不同随机分为两组,观察组患者接受葛根芩连汤联合西药治疗,对照组患者接受常规西药治疗,比较两组患者的临床症状和体征缓解时间、血氧饱和度以及免疫功能。结果 (1)症状和体征缓解时间:观察组患儿的咳嗽、喘憋缓解时间以及两肺啰音消失时间分别为(3.35±0.42)、(1.75±0.23)、(3.58±0.45)d,均短于对照组的(4.95±0.62)、(2.84±0.40)、(5.91±0.71)d;(2)血氧饱和度:治疗后1、2、3 d时,观察组患儿的血氧饱和度分别为(95.33±12.24)%、(97.58±11.94)%、(99.13±12.85)%,高于对照组的(91.98±10.85)%、(93.54±12.38)%、(95.16±14.23)%;(3)免疫功能:观察组患儿的血清Ig G(6.25±0.82)、Ig M(0.82±0.10)、Ig A(0.42±0.05)g/L,高于对照组的(4.34±0.65)、(0.58±0.06)、(0.29±0.03)g/L。结论葛根芩连汤联合西药治疗有助于促进临床症状和体征缓解、提高血氧饱和度、增强免疫功能,是治疗小儿毛细支气管炎的理想方法。     

Simultaneous determination of albiflorin and paeoniflorin in rat urine by solid-phase extraction and high-performance liquid chromatography following oral administration of Si-Wu decoction

A high performance liquid chromatographic method (HPLC), together with solid phase extraction (SPE), was developed for simultaneous determination of albiflorin and paeoniflorin in rat urine after oral administration of Si-Wu decoction. The samples were pretreated with solid phase extraction using Extract-Cleantrade mark cartridges. Analysis of the extract was performed on a reversed-phase C18 column and a mobile phase made up of acetonitrile and 0.03% formic acid (17:83, v/v). UV detection was set at 230 nm. The assay was linear over the range 2.625-52.50 mg/mL for albiflorin and 3.875-77.50 microg/mL for paeoniflorin. The average percentage recoveries of three spiked urines were 97.01 +/- 3.32 and 102.32 +/- 6.97 for albiflorin and paeoniflorin, respectively. The intra-day precision (RSD) ranged from 0.21 to 1.79% at concentrations of 4.20, 10.50, 26.25 and 39.375 microg/mL of albiflorin and 0.12 to 2.92% at concentrations of 3.875, 10.85, 23.25 and 58.125 microg/mL of paeoniflorin, and inter-day precision (RSD) was from 1.02 to 1.86% for albiflorin and 0.94 to 3.30% for paeoniflorin, at the same four concentrations. This method was applied in order to analyze albiflorin and paeoniflorin in rat urine following oral administration of traditional Chinese medicinal preparation of Si-Wu decoction.     

In vivo metabolism study of rhubarb decoction in rat using high-performance liquid chromatography with UV photodiode-array and mass-spectrometric detection: a strategy for systematic analysis of metabolites from traditional Chinese medicines in biological samples

High-performance liquid chromatography with diode-array detection (HPLC-DAD) and tandem mass spectrometry (HPLC-MS/MS) was used for separation and identification of metabolites in rat urine, bile and plasma after oral administration of rhubarb decoction. Based on the proposed strategy, 91 of the 113 potential metabolites were tentatively identified or characterized. Besides anthraquinones metabolites, gallic acid, (-)-epicatechin and (+)-catechin metabolites were also detected and characterized in these biological samples. Our results indicated that glucuronidation and sulfation were the main metabolic pathways of anthraquinones, while methylation, glucuronidation and sulfation were the main metabolic pathways of gallic acid, (-)-epicatechin and (+)-catechin. Phase I reactions (e.g., hydroxylation and reduction) played a relatively minor role compared to phase II reactions in metabolism of phenolic compounds of rhubarb decoction. The identification and structure elucidation of these metabolites provided essential data for further pharmacological and clinical studies of rhubarb and related preparations. Moreover, the results of the present investigations clearly indicated the relevance and usefulness of the combination of chromatographic, spectrophotometric, and mass-spectrometric analysis to detect and identify metabolites.     

高效液相色谱-蒸发光散射检测法同时测定四君子丸中的5种有效成分

建立了同时测定四君子丸中党参炔苷、茯苓酸、甘草酸、苍术内酯III和白术内酯I含量的高效液相色谱法。色谱条件为: HIQ SIL C18 V色谱柱(250 mm×4.6 mm, 5 μm),以0.5%冰乙酸-甲醇体系为流动相进行梯度洗脱,流速为1.0 mL/min,采用蒸发光散射检测器检测,进样量为10 μL,柱温为25 ℃,漂移管温度为55 ℃,喷雾器加热级别为60%,载气为氮气,压力0.2 MPa。在上述条件下,党参炔苷、茯苓酸、甘草酸、苍术内酯III和白术内酯I的质量浓度分别在0.076～1.21, 0.048～0.76, 0.153～2.45, 0.045～0.72和0.098～1.56 g/L时,质量浓度的对数值与色谱峰面积的对数值之间的线性关系良好;平均回收率在97.13%～100.25%之间,相对标准偏差在1.23%～2.44%之间。该方法简便、快速、准确,可用于四君子丸的质量控制。     

Roles of paeoniflorin and senkyunolide I in SiWu decoction on antiplatelet and anticoagulation activities

Traditional Chinese medicine (TCM) is a complex system, which consists of numerous compounds with related mechanisms to maximize therapeutic efficacy with minimal adverse effects. Some new methods disclosing the contribution of these constituents as well as their relationship in the formula are necessary for elucidating the bio‐active constituents and the working mechanisms of TCM. In this study, depletion of target components using preparative HPLC followed by antiplatelet and anticoagulation activities evaluation was first applied to investigate the roles of paeoniflorin and senkyunolide I in a well‐known formula, SiWu decoction. The results showed that both paeoniflorin and senkyunolide I not only directly brought about some bio‐activities, but also indirectly made the contribution to the total bio‐activity reflection of SiWu decoction, especially the latter should deserve to be drawn attention to the research of complicated bio‐active constituents of TCM or its formula. So, the significant and effective approach will be very useful for the elucidation of the contribution of each different chemical constituent to the bio‐activity of a TCM formula. Furthermore, this study demonstrated the potential utilization of preparative HPLC in the research of TCM.     

Homotherapy for heteropathy active components and mechanisms of Qiang-Huo-Sheng-Shi decoction for treatment of rheumatoid arthritis and osteoarthritis

Qiang-Huo-Sheng-Shi decoction (QHSSD), a classic traditional Chinese herbal formula, which has been reported to be effective in rheumatoid arthritis (RA) and osteoarthritis (OA). However, the concurrent targeting mechanism of how the aforementioned formula is valid in the two distinct diseases OA and RA, which represents the homotherapy-for-heteropathy principle in traditional Chinese medicine (TCM), have not yet been clarified. In the present study, network pharmacology was adopted to analyze the potential molecular mechanism, and therapeutic effective components of QHSSD on both OA and RA. A total of 153 active ingredients in QHSSD were identified, 142 of which associated with 59 potential targets for the two diseases were identified. By constructing the protein-protein interaction network and the compound-target-disease network, 72 compounds and 10 proteins were obtained as the hub targets of QHSSD against OA and RA. The hub genes of ESR1, PTGS2, PPARG, IL1B, TNF, MMP2, IL6, CYP3A4, MAPK8, and ALB were mainly involved in osteoclast differentiation, the NF-κB and TNF signaling pathways. Moreover, molecular docking results showed that the screened active compounds had a high affinity for the hub genes. This study provides new insight into the molecular mechanisms behind how QHSSD presents homotherapy-for-heteropathy therapeutic efficacy in both OA and RA. For the first time, a two-disease model was linked with a TCM formula using network pharmacology to identify the key active components and understand the common mechanisms of its multi-pathway regulation. This study will inspire more innovative and important studies on the modern research of TCM formulas.